Chemical and Structural Biology to Direct the Repurposing of Sulindac

Chemical biology for medicinal chemistry: The nonsteroidal anti‐inflammatory drug sulindac was originally developed to inhibit cyclooxygenase enzymes (COX1/2) to treat inflammation and pain. Recent studies have shown that sulindac also acts on the Wnt signaling pathway, a target relevant to cancer....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	ChemMedChem 2009-11, Vol.4 (11), p.1793-1795
Hauptverfasser:	Simard, Jeffrey R., Rauh, Daniel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adaptor Proteins, Signal Transducing - chemistry Adaptor Proteins, Signal Transducing - metabolism Anti-Inflammatory Agents, Non-Steroidal - chemistry Binding Sites cancer chemical biology Computer Simulation Cyclooxygenase Inhibitors - chemistry Dishevelled Proteins medicinal chemistry NMR Phosphoproteins - chemistry Phosphoproteins - metabolism Prostaglandin-Endoperoxide Synthases - metabolism Protein Structure, Tertiary protein-ligand interactions Signal Transduction Sulindac - chemistry Wnt Proteins - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Chemical biology for medicinal chemistry: The nonsteroidal anti‐inflammatory drug sulindac was originally developed to inhibit cyclooxygenase enzymes (COX1/2) to treat inflammation and pain. Recent studies have shown that sulindac also acts on the Wnt signaling pathway, a target relevant to cancer.
ISSN:	1860-7179 1860-7187
DOI:	10.1002/cmdc.200900384